Tony A Cohn

Summary

Affiliation: Centre for Addiction and Mental Health
Country: Canada

Publications

  1. ncbi request reprint Metabolic monitoring for patients treated with antipsychotic medications
    Tony A Cohn
    Centre for Addiction and Mental Health, Toronto, Ontario
    Can J Psychiatry 51:492-501. 2006
  2. ncbi request reprint Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome
    Tony Cohn
    Department of Psychiatry, University of Toronto, and Center for Addiction and Mental Health, Toronto, Ontario
    Can J Psychiatry 49:753-60. 2004
  3. ncbi request reprint Insulin resistance and adiponectin levels in drug-free patients with schizophrenia: A preliminary report
    Tony A Cohn
    Department of Psychiatry, Faculty of Medicine, University of Toronto, Ontario
    Can J Psychiatry 51:382-6. 2006
  4. ncbi request reprint Pharmacologic and nonpharmacologic strategies for weight gain and metabolic disturbance in patients treated with antipsychotic medications
    Guy Faulkner
    Faculty of Physical Education and Health, University of Toronto, Ontario
    Can J Psychiatry 51:502-11. 2006
  5. doi request reprint Schizophrenia and the incidence of cardiovascular morbidity: a population-based longitudinal study in Ontario, Canada
    Russell C Callaghan
    Centre for Addiction and Mental Health, 33 Russell St, Toronto, ON, Canada
    Schizophr Res 115:325-32. 2009
  6. doi request reprint Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration
    Araba F Chintoh
    Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada
    J Clin Psychopharmacol 28:494-9. 2008
  7. doi request reprint Psychiatric illness and obesity: recognizing the "obesogenic" nature of an inpatient psychiatric setting
    Guy E J Faulkner
    Faculty of Physical Education and Health, University of Toronto, 55 Harbord St, Toronto, Ontario, Canada
    Psychiatr Serv 60:538-41. 2009
  8. doi request reprint Atypical antipsychotics and diabetic ketoacidosis: a review
    Melanie D Guenette
    Institute of Medical Science, Faculty of Medicine, University of Toronto, Medical Sciences Building, 1 King s College Circle, Room 2374, Toronto, Ontario, Canada M5S 1A8
    Psychopharmacology (Berl) 226:1-12. 2013
  9. doi request reprint Smoking cessation in women with severe mental illness: exploring the role of exercise as an adjunct treatment
    Kelly P Arbour-Nicitopoulos
    Faculty of Physical Education and Health, University of Toronto, Toronto, ON, Canada
    Arch Psychiatr Nurs 25:43-52. 2011
  10. pmc Interventions to reduce weight gain in schizophrenia
    Guy Faulkner
    Faculty of Physical Education and Health, University of Toronto, Toronto, Canada
    Schizophr Bull 33:654-6. 2007

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Metabolic monitoring for patients treated with antipsychotic medications
    Tony A Cohn
    Centre for Addiction and Mental Health, Toronto, Ontario
    Can J Psychiatry 51:492-501. 2006
    ..Our objectives were to review published international monitoring guidelines, establish goals for metabolic monitoring, and make recommendations for practice...
  2. ncbi request reprint Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome
    Tony Cohn
    Department of Psychiatry, University of Toronto, and Center for Addiction and Mental Health, Toronto, Ontario
    Can J Psychiatry 49:753-60. 2004
    ..To determine the prevalence and characteristics of coronary heart disease (CHD) risk factors in patients with chronic schizophrenia or schizoaffective disorder...
  3. ncbi request reprint Insulin resistance and adiponectin levels in drug-free patients with schizophrenia: A preliminary report
    Tony A Cohn
    Department of Psychiatry, Faculty of Medicine, University of Toronto, Ontario
    Can J Psychiatry 51:382-6. 2006
    ..To compare the insulin sensitivity and adiponectin levels of medication-free patients suffering from schizophrenia or schizoaffective disorder with that of matched healthy volunteers...
  4. ncbi request reprint Pharmacologic and nonpharmacologic strategies for weight gain and metabolic disturbance in patients treated with antipsychotic medications
    Guy Faulkner
    Faculty of Physical Education and Health, University of Toronto, Ontario
    Can J Psychiatry 51:502-11. 2006
    ....
  5. doi request reprint Schizophrenia and the incidence of cardiovascular morbidity: a population-based longitudinal study in Ontario, Canada
    Russell C Callaghan
    Centre for Addiction and Mental Health, 33 Russell St, Toronto, ON, Canada
    Schizophr Res 115:325-32. 2009
    ....
  6. doi request reprint Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration
    Araba F Chintoh
    Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada
    J Clin Psychopharmacol 28:494-9. 2008
    ..We present novel findings highlighting an olanzapine-induced deficit in beta-cell functioning...
  7. doi request reprint Psychiatric illness and obesity: recognizing the "obesogenic" nature of an inpatient psychiatric setting
    Guy E J Faulkner
    Faculty of Physical Education and Health, University of Toronto, 55 Harbord St, Toronto, Ontario, Canada
    Psychiatr Serv 60:538-41. 2009
    ..This study examined environmental factors that contribute to obesity in one psychiatric hospital in Canada...
  8. doi request reprint Atypical antipsychotics and diabetic ketoacidosis: a review
    Melanie D Guenette
    Institute of Medical Science, Faculty of Medicine, University of Toronto, Medical Sciences Building, 1 King s College Circle, Room 2374, Toronto, Ontario, Canada M5S 1A8
    Psychopharmacology (Berl) 226:1-12. 2013
    ..Atypical antipsychotics have been linked to weight gain and type 2 diabetes, but are also associated with diabetic ketoacidosis (DKA), which can occur more acutely and in the absence of weight gain...
  9. doi request reprint Smoking cessation in women with severe mental illness: exploring the role of exercise as an adjunct treatment
    Kelly P Arbour-Nicitopoulos
    Faculty of Physical Education and Health, University of Toronto, Toronto, ON, Canada
    Arch Psychiatr Nurs 25:43-52. 2011
    ..The aim of this study was to investigate the potential role of exercise in smoking cessation in women with severe mental illness (SMI)...
  10. pmc Interventions to reduce weight gain in schizophrenia
    Guy Faulkner
    Faculty of Physical Education and Health, University of Toronto, Toronto, Canada
    Schizophr Bull 33:654-6. 2007
  11. ncbi request reprint Body mass index, waist circumference and quality of life in individuals with schizophrenia
    Guy Faulkner
    Faculty of Physical Education and Health, University of Toronto, Ontario, Canada M5S 2W6
    Schizophr Res 90:174-8. 2007
    ..The primary objective was to examine the differential relationship between waist circumference, body mass index, and self-reported quality of life in patients with schizophrenia...
  12. ncbi request reprint Validation of a physical activity assessment tool for individuals with schizophrenia
    Guy Faulkner
    Faculty of Physical Education and Health, University of Toronto, 55 Harbord Street, Toronto, Ontario, Canada M5S 2W6
    Schizophr Res 82:225-31. 2006
    ..The objective of this study was to provide preliminary validation of the Short-Form International Physical Activity Questionnaire (IPAQ), a measurement tool that could prove useful for both clinicians and researchers in the field...
  13. ncbi request reprint Hyperinsulinemia in psychiatric patients treated with olanzapine
    Tony A Cohn
    J Clin Psychiatry 63:75-6. 2002